Holen Sie sich die Stockscreener-App
63.02
0.68%
-0.43
Schlusskurs vom Vortag:
$63.45
Offen:
$63.7
24-Stunden-Volumen:
968.13K
Relative Volume:
1.27
Marktkapitalisierung:
$3.17B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
26.15
EPS:
2.41
Netto-Cashflow:
$20.35M
1W Leistung:
+1.06%
1M Leistung:
-16.24%
6M Leistung:
-16.43%
1J Leistung:
-13.99%
1-Tages-Spanne:
$62.38
$64.31
1-Wochen-Bereich:
$61.64
$65.14
52-Wochen-Spanne:
$58.80
$97.97
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
63.02 | 3.17B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World
(HAE)Analyzing Haemonetics's Short Interest - Benzinga
SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World
Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat
Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat
Haemonetics (NYSE:HAE) Price Target Cut to $100.00 by Analysts at JMP Securities - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives $101.67 Consensus Target Price from Analysts - Defense World
Haemonetics (NYSE:HAE) Raised to "Buy" at StockNews.com - MarketBeat
Haemonetics (NYSE:HAE) Downgraded to Underperform Rating by Bank of America - MarketBeat
Haemonetics' (HAE) "Strong-Buy" Rating Reaffirmed at Raymond James - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 52-Week Low After Analyst Downgrade - Defense World
Barrington Research Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Haemonetics (NYSE:HAE) Upgraded at StockNews.com - Defense World
Haemonetics (NYSE:HAE) Shares Gap Down Following Weak Earnings - MarketBeat
It is Poised to be a Bull Market for Haemonetics Corp (HAE) - SETE News
Haemonetics (HAE) Projected to Post Earnings on Thursday - MarketBeat
Haemonetics (NYSE:HAE) Releases FY 2025 Earnings Guidance - MarketBeat
Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat
Haemonetics (HAE) Q3 Earnings Meet Estimates - MSN
Haemonetics Corp [HAE] Former Officer makes an insider purchase of 6,238 shares worth 0.57 million. - Knox Daily
Haemonetics' stock slides on revenue miss - MSN
Needham & Company LLC Lowers Haemonetics (NYSE:HAE) Price Target to $108.00 - Armenian Reporter
Haemonetics Corporation (NYSE:HAE) Q3 2025 Earnings Call Transcript - Insider Monkey
Haemonetics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma Revenue Challenges - GuruFocus.com
Haemonetics (NYSE:HAE) Shares Gap Down After Earnings Miss - Defense World
Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... - Yahoo Finance
Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... By GuruFocus - Investing.com Canada
Boston Trust Walden Corp Has $71.50 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Earnings call transcript: Haemonetics Q3 2024 sees EPS beat, stock drops - MSN
FY2025 EPS Estimates for Haemonetics Reduced by Analyst - MarketBeat
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 28, 2024 - Marketscreener.com
Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Haemonetics earnings beat by $0.02, revenue fell short of estimates - Investing.com
Haemonetics Corp Q3 Earnings: EPS at $0.74 Misses Estimates, Rev - GuruFocus.com
HAEMONETICS Earnings Results: $HAE Reports Quarterly Earnings - Nasdaq
Haemonetics: Fiscal Q3 Earnings Snapshot -February 06, 2025 at 06:40 am EST - Marketscreener.com
Haemonetics Narrows FY25 Adj. EPS Outlook Range, But Trims Revenue GrowthUpdate - Nasdaq
Haemonetics Corp Reports Q3 Revenue Of $348.5 Million, Up 3.7% YoY -February 06, 2025 at 06:29 am EST - Marketscreener.com
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):